Collegeville, PA, United States of America

Louis Lafrance


 

Average Co-Inventor Count = 10.7

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Louis Lafrance

Introduction

Louis Lafrance is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are useful for treating cancer. With a total of 4 patents to his name, Lafrance has established himself as a key figure in his industry.

Latest Patents

Among his latest patents are innovative compounds such as indazoles and indoles. The indazoles are disclosed with a specific formula (I), where various groups are defined, showcasing their potential utility in cancer treatment. Similarly, the indoles, also defined by a formula (I), present promising applications in the same therapeutic area.

Career Highlights

Louis Lafrance is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His work at GlaxoSmithKline has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His dedication to innovation has led to the creation of valuable patents that contribute to advancements in cancer treatment.

Collaborations

Lafrance has collaborated with esteemed colleagues such as Neil W. Johnson and Steven David Knight. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to significant breakthroughs in their field.

Conclusion

In summary, Louis Lafrance is a distinguished inventor whose work in pharmaceuticals has led to the development of important cancer treatment compounds. His contributions through patents and collaborations highlight his commitment to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…